Revised U.S. Food and Drug Administration Trial Eligibility Guidance: A Major Step Toward Transforming Lung Cancer Clinical Trials

Liquid Biopsy: The Key Weapon for Real-Time Monitoring of Patients With NSCLC 

Lung Cancer Screening in Poland Pilot Program Is Restarted After COVID-19 Lockdown

FDA’s Project Patient Voice Launched to Provide Data on PROs

Multidisciplinary EURACAN/IASLC Proposal for Revision of the Histologic Classification of Malignant Pleural Mesothelioma 

Controversy Regarding U.S. Marketing of New Heated Tobacco Product IQOS

A New Year’s Resolution to Promote the Use of Patient-Sensitive Language

WCLC Conference Chairs Offer Insights on The New All-Virtual Program, The Year Ahead

2020 Adi F. Gazdar IASLC Merit Award Recipient: Dr. Alex A. Adjei

Role of Thai Oncology Pharmacists in Lung Cancer Treatment: A Q&A With Dr. Suthan Chanthawong

PD-L1 Blockade Reinvigorates Dendritic Cells for Antitumor Immunity